Univ Minnesota, Sch Dent, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA.
Univ Laval, Fac Dent, Sect Stomatol, Quebec City, PQ, Canada.
Malmö högskola, Faculty of Odontology (OD).
Aarhus Univ, Dept Clin Oral Physiol, Sch Dent, Aarhus, Denmark; Aarhus Univ Hosp, MindLab, Ctr Functionally Integrat Neurosci, DK-8000 Aarhus, Denmark.
SUNY Buffalo, Sch Dent Med, Dept Oral Diagnost Sci, New York, NY USA.
Univ Amsterdam, Dept Oral Kinesiol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.
Univ Naples Federico II, Sch Dent, Dept Orthodont & Gnathol, Naples, Italy.
Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.
SUNY Buffalo, Dept Psychiat, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; Inst Healthcare Informat, Buffalo, NY USA; New York State Ctr Excellence Bioinformat & Life, Ontol Res Grp, Buffalo, NY USA.
Univ Washington, Sch Dent, Dept Oral Med, Seattle, WA 98195 USA.
Univ Zurich, Zurich, Switzerland.
Migraine & Headache Clin, Konigstein, Germany.
SUNY Buffalo, Sch Dent Med, Dept Oral Diagnost Sci, New York, NY USA.
Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
Univ Washington, Sch Dent, Dept Oral Med, Seattle, WA 98195 USA.
Univ Copenhagen, Dept Neurol, Glostrup Hosp, Danish Headache Ctr, Copenhagen, Denmark.
Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN USA.
Katholieke Univ Leuven, Dept Oral Hlth Sci, Leuven, Belgium; Katholieke Univ Leuven Hosp, Dept Radiol, B-3000 Leuven, Belgium.
Univ Kentucky, Coll Dent, Dept Oral Hlth Sci, Lexington, KY USA.
Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC USA.
Univ Amsterdam, Dept Oral Kinesiol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.
Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia.
Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; HealthPartners Inst Educ & Res, Bloomington, MN USA.
Univ Zurich, Zurich, Switzerland.
Malmö högskola, Faculty of Odontology (OD).
Univ Auvergne, Fac Odontol, Dept Orofacial Pain, Clermont Ferrand, France; Univ Auvergne, Fac Odontol, Dept Psychol, Clermont Ferrand, France.
SUNY Buffalo, Dept Philosophy, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Comp Sci, Buffalo, NY 14260 USA.
Univ Amsterdam, Dept Oral Kinesiol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.
UCLH NHS Fdn Trust, Eastman Dent Hosp, Div Diagnost Surg & Med Sci, London, England.
Univ Washington, Sch Dent, Dept Oral Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
Aims: The original Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I diagnostic algorithms have been demonstrated to be reliable. However, the Validation Project determined that the RDC/TMD Axis I validity was below the target sensitivity of ≥ 0.70 and specificity of ≥ 0.95. Consequently, these empirical results supported the development of revised RDC/TMD Axis I diagnostic algorithms that were subsequently demonstrated to be valid for the most common pain-related TMD and for one temporomandibular joint (TMJ) intra-articular disorder. The original RDC/TMD Axis II instruments were shown to be both reliable and valid. Working from these findings and revisions, two international consensus workshops were convened, from which recommendations were obtained for the finalization of new Axis I diagnostic algorithms and new Axis II instruments.
Methods: Through a series of workshops and symposia, a panel of clinical and basic science pain experts modified the revised RDC/TMD Axis I algorithms by using comprehensive searches of published TMD diagnostic literature followed by review and consensus via a formal structured process. The panel's recommendations for further revision of the Axis I diagnostic algorithms were assessed for validity by using the Validation Project's data set, and for reliability by using newly collected data from the ongoing TMJ Impact Project-the follow-up study to the Validation Project. New Axis II instruments were identified through a comprehensive search of the literature providing valid instruments that, relative to the RDC/TMD, are shorter in length, are available in the public domain, and currently are being used in medical settings.
Results: The newly recommended Diagnostic Criteria for TMD (DC/TMD) Axis I protocol includes both a valid screener for detecting any pain-related TMD as well as valid diagnostic criteria for differentiating the most common pain-related TMD (sensitivity ≥ 0.86, specificity ≥ 0.98) and for one intra-articular disorder (sensitivity of 0.80 and specificity of 0.97). Diagnostic criteria for other common intra-articular disorders lack adequate validity for clinical diagnoses but can be used for screening purposes. Inter-examiner reliability for the clinical assessment associated with the validated DC/TMD criteria for pain-related TMD is excellent (kappa ≥ 0.85). Finally, a comprehensive classification system that includes both the common and less common TMD is also presented. The Axis II protocol retains selected original RDC/TMD screening instruments augmented with new instruments to assess jaw function as well as behavioral and additional psychosocial factors. The Axis II protocol is divided into screening and comprehensive self report instrument sets. The screening instruments' 41 questions assess pain intensity, pain-related disability, psychological distress, jaw functional limitations, and parafunctional behaviors, and a pain drawing is used to assess locations of pain. The comprehensive instruments, composed of 81 questions, assess in further detail jaw functional limitations and psychological distress as well as additional constructs of anxiety and presence of comorbid pain conditions.
Conclusion: The recommended evidence-based new DC/TMD protocol is appropriate for use in both clinical and research settings. More comprehensive instruments augment short and simple screening instruments for Axis I and Axis II. These validated instruments allow for identification of patients with a range of simple to complex TMD presentations.